A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

Please provide your email address to receive an email when new articles are posted on . Miller-Owen: Close to 8 million U.S. residents with diabetes are on insulin therapy, and the clear majority use ...

Many people who inject themselves with insulin to control diabetes are improperly performing this vital task, according to a large new study. Based on the results, experts have crafted recommendations ...

One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...

Glucose (blood sugar) is made and released by the liver when you’re in a post-meal or fasting state. Basal insulin allows the cells of the body to use this glucose for energy and to keep blood sugar ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market are the rising prevalence of diabetes, the growing preference for pens over ...

One of the many curses of diabetes is having to inject insulin, and there's an entire industry dedicated to making it easy and painless. Eli Lilly's insulin pen might not make it insulin any less ...

As if all the side effects and health concerns related to diabetes weren’t enough, those dealing with the condition also have to maintain a frequent and carefully tracked regiment of insulin ...

A diabetic applies an Insulin pen injection in Vienna November 13, 2012. Picture taken November 13, 2012. REUTERS/Heinz-Peter Bader By Andrew M. Seaman (Reuters Health) - Many people who inject ...